Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese

Neurobiology of Aging

Volumn 34, Issue 7, 2013, Pages 1921.e17-1921.e23

  Yu, Jin Tai ^a,b   Ma, Xiao Ying ^b,c   Wang, Ying Li ^b   Sun, Lei ^b   Tan, Lin ^b   Hu, Nan ^b   Tan, Lan ^a,b  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b QINGDAO UNIVERSITY   (China)

^c Guihang Guiyang Hospital   (China)

Author keywords

Alzheimer's Disease; Association study; Clusterin; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; CLUSTERIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHINESE; CLU GENE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION;

EID: 84875827207     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.01.010     Document Type: Article

References (42)

1. Barral S., Bird T., Goate A., Farlow M.R., Diaz-Arrastia R., Bennett D.A., Graff-Radford N., Boeve B.F., Sweet R.A., Stern Y., Wilson R.S., Foroud T., Ott J., Mayeux R., National Institute on Aging Late-Onset Alzheimer's Disease Genetics Study Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology 2012, 78:1464-1471.
2. Bekris L.M., Yu C.E., Bird T.D., Tsuang D.W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 2010, 23:213-227.
3. Bell R.D., Sagare A.P., Friedman A.E., Bedi G.S., Holtzman D.M., Deane R., Zlokovic B.V. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 2007, 27:909-918.
4. Bertram L., Tanzi R.E. The genetics of Alzheimer's disease. Prog. Mol. Biol. Transl. Sci. 2012, 107:79-100.
5. Bettens K., Brouwers N., Engelborghs S., Lambert J.C., Rogaeva E., Vandenberghe R., Le Bastard N., Pasquier F., Vermeulen S., Van Dongen J., Mattheijssens M., Peeters K., Mayeux R., St George-Hyslop P., Amouyel P., De Deyn P.P., Sleegers K., Van Broeckhoven C. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol. Neurodegener. 2012, 16:3.
6. Butler A.W., Ng M.Y., Hamshere M.L., Forabosco P., Wroe R., Al-Chalabi A., Lewis C.M., Powell J.F. Meta-analysis of linkage studies for Alzheimer's disease-a web resource. Neurobiol. Aging 2009, 30:1037-1047.
7. Carrasquillo M.M., Belbin O., Hunter T.A., Ma L., Bisceglio G.D., Zou F., Crook J.E., Pankratz V.S., Dickson D.W., Graff-Radford N.R., Petersen R.C., Morgan K., Younkin S.G. Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch. Neurol. 2010, 67:961-964.
8. Chen J., Wang M., Turko I.V. Mass spectrometry quantification of clusterin in the human brain. Mol. Neurodegener. 2012, 20:41. 10.1186/1750-1326-7-41.
9. Corneveaux J.J., Myers A.J., Allen A.N., Pruzin J.J., Ramirez M., Engel A., Nalls M.A., Chen K., Lee W., Chewning K., Villa S.E., Meechoovet H.B., Gerber J.D., Frost D., Benson H.L., O'Reilly S., Chibnik L.B., Shulman J.M., Singleton A.B., Craig D.W., Van Keuren-Jensen K.R., Dunckley T., Bennett D.A., De Jager P.L., Heward C., Hardy J., Reiman E.M., Huentelman M.J. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum. Mol. Genet. 2010, 19:3295-3301.
10. DeMattos R.B., O'dell M.A., Parsadanian M., Taylor J.W., Harmony J.A., Bales K.R., Paul S.M., Aronow B.J., Holtzman D.M. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A 2002, 99:10843-10848.
11. de Silva H.V., Harmony J.A., Stuart W.D., Gil C.M., Robbins J. Apolipoprotein J: structure and tissue distribution. Biochemistry 1990, 29:5380-5389.
12. Ferrari R., Moreno J.H., Minhajuddin A.T., O'Bryant S.E., Reisch J.S., Barber R.C., Momeni P. Implication of common and disease specific variants in CLU, CR1, and PICALM. Neurobiol. Aging 2012, 33:1846.e7-1846.e18.
13. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 2006, 63:168-174.
14. Gu H., Wei X., Chen S., Kurz A., Müller U., Gasser T., Dodel R.C., Farlow M.R., Du Y. Association of clusterin gene polymorphisms with late-onset Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2011, 32:198-201.
15. Guerreiro R.J., Beck J., Gibbs J.R., Santana I., Rossor M.N., Schott J.M., Nalls M.A., Ribeiro H., Santiago B., Fox N.C., Oliveira C., Collinge J., Mead S., Singleton A., Hardy J. Genetic variability in CLU and its association with Alzheimer's disease. PLoS One 2010, 5:e9510.
16. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
17. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schürmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Hüll M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
18. Jun G., Naj A.C., Beecham G.W., Wang L.S., Buros J., Gallins P.J., Buxbaum J.D., Ertekin-Taner N., Fallin M.D., Friedland R., Inzelberg R., Kramer P., Rogaeva E., St George-Hyslop P., Cantwell L.B., Dombroski B.A., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Lunetta K.L., Martin E.R., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Beekly D., Cupples L.A., Hakonarson H., Kukull W., Foroud T.M., Haines J., Mayeux R., Farrer L.A., Pericak-Vance M.A., Schellenberg G.D. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 2010, 67:1473-1484. Alzheimer's Disease Genetics Consortium.
19. Kamboh M.I., Minster R.L., Demirci F.Y., Ganguli M., Dekosky S.T., Lopez O.L., Barmada M.M. Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol. Aging 2012, 33:518-521.
20. Komatsu M., Shibata N., Kuerban B., Ohnuma T., Baba H., Arai H. Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population. Psychogeriatrics 2011, 11:14-18.
21. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., EuropeanAlzheimer's Disease Initiative Investigators, de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated withAlzheimer's disease. Nat. Genet. 2009, 41:1094-1099.
22. Lee J.H., Cheng R., Barral S., Reitz C., Medrano M., Lantigua R., Jiménez-Velazquez I.Z., Rogaeva E., St George-Hyslop P.H., Mayeux R. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch. Neurol. 2011, 68:320-328.
23. Lidström A.M., Bogdanovic N., Hesse C., Volkman I., Davidsson P., Blennow K. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp. Neurol. 1998, 154:511-521.
24. Lin Y.L., Chen S.Y., Lai L.C., Chen J.H., Yang S.Y., Huang Y.L., Chen T.F., Sun Y., Wen L.L., Yip P.K., Chu Y.M., Chen W.J., Chen Y.C. Genetic polymorphisms of clusterin gene are associated with a decreased risk of Alzheimer's disease. Eur. J. Epidemiol. 2012, 27:73-75.
25. Makhanova N., Hagaman J., Kim H.S., Smithies O. Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension 2008, 51:134-140.
26. Manikandan M., Raksha G., Munirajan A.K. Haploinsufficiency of tumor suppressor genes is driven by the cumulative effect of microRNAs, microRNA binding site polymorphisms and microRNA polymorphisms: an in silico approach. Cancer Inform. 2012, 11:157-171.
27. Matsubara E., Soto C., Governale S., Frangione B., Ghiso J. Apolipoprotein J and Alzheimer's amyloid beta solubility. Biochem. J. 1996, 316:671-679.
28. May P.C., Lampert-Etchells M., Johnson S.A., Poirier J., Masters J.N., Finch C.E. Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 1990, 5:831-839.
29. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer'sdisease. Nat. Genet. 2011, 43:436-441.
30. Nilselid A.M., Davidsson P., Nagga K., Andreasen N., Fredman P., Blennow K. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem. Int. 2006, 48:718-728.
31. Oda T., Pasinetti G.M., Osterburg H.H., Anderson C., Johnson S.A., Finch C.E. Purification and characterization of brain clusterin. Biochem Biophys Res Commun. 1994, 204:1131-1136.
32. Schjeide B.M., Schnack C., Lambert J.C., Lill C.M., Kirchheiner J., Tumani H., Otto M., Tanzi R.E., Lehrach H., Amouyel P., von Arnim C.A., Bertram L. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Arch. Gen. Psychiatry 2011, 68:207-213.
33. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
34. Sillén A., Lilius L., Forsell C., Kimura T., Winblad B., Graff C. Linkage to the 8p21.1 region Including the CLU gene in age at onset stratified Alzheimer's disease families. J. Alzheimers Dis. 2011, 23:13-20.
35. Tan L., Yu J.T., Hu N., Tan L. Non-coding RNAs in Alzheimer's disease. Mol. Neurobiol. 2013, 47:382-393.
36. Tycko B., Feng L., Nguyen L., Francis A., Hays A., Chung W.Y., Tang M.X., Stern Y., Sahota A., Hendrie H., Mayeux R. Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Hum. Genet. 1996, 98:430-436.
37. Wu Z.C., Yu J.T., Li Y., Tan L. Clusterin in Alzheimer's disease. Adv. Clin. Chem. 2012, 56:155-173.
38. Xing Y.Y., Yu J.T., Cui W.Z., Zhong X.L., Wu Z.C., Zhang Q., Tan L. Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. J. Alzheimers Dis. 2012, 29:515-519.
39. Yerbury J.J., Poon S., Meehan S., Thompson B., Kumita J.R., Dobson C.M., Wilson M.R. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 2007, 21:2312-2322.
40. Yu J.T., Li L., Zhu Q.X., Zhang Q., Zhang W., Wu Z.C., Guan J., Tan L. Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. Clin. Chim. Acta. 2010, 411:1516-1519.
41. Yu J.T., Tan L. The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy. Mol. Neurobiol. 2012, 45:314-326.
42. Zlokovic B.V., Deane R., Sallstrom J., Chow N., Miano J.M. Neurovascular pathways and Alzheimer amyloid beta-peptide. Brain Pathol. 2005, 15:78-83.